June 16, 2014 News by Patricia Silva, PhD Researcher Recommends Brain Imaging To Treat MS-Related Depression Magnetic resonance imaging (MRI) can predict responses to depression treatment in patients with multiple sclerosis (MS), according to Anthony Feinstein, Professor at the Department of Psychiatry of the Sunnybrook Health Sciences Centre & the University of Toronto. In the presentation “Depression in MS: Is brain imaging helpful?” at this…
June 6, 2014 by Patricia Silva, PhD Researchers Present Guide To Compassion Fatigue Fighting Through Self Care At MS Conference The first step to effective caregiving for those with Multiple Sclerosis is caring for oneself, according to researchers Marie Namey, a clinical nurse specialist in Multiple Sclerosis at the Cleveland Clinic Main Campus, and Ellen Reardon, a dietitian at Walden Behavioral Care. The presentation “Compassion Fatigue: Caring for the…
June 5, 2014 News by Patricia Silva, PhD International Committee Recommends Revision of MS Definitions snig / Shutterstock.com Following yesterday’s publication of “Multiple Sclerosis Management – A Changing Landscape 2013,” a report outlining ongoing goals and focus points for advancing MS drugs and treatments, as a result of a meeting of specialists in Vienna, Austria, a new article…
June 4, 2014 News by Patricia Silva, PhD New Report Outlines Scholars’ Meeting Concerns Over MS Treatment, Drug Development A new report was recently released outlining researchers’ ongoing goals and focus points for advancing MS drug development and treatment options. “Multiple Sclerosis Management – A Changing Landscape 2013” is the result of a meeting held in Vienna, Austria in April of 2013 that brought together 372…
June 2, 2014 News by Patricia Silva, PhD UT Medicine Multiple Sclerosis Clinic Selected As MS Partner In Care The network of nationally recognized Multiple Sclerosis centers continues to grow throughout the United States. Recently, the Multiple Sclerosis Clinic at University of Texas (UT) Medicine San Antonio was selected as the new Multiple Sclerosis Partner in Care, a recognition granted by the National Multiple Sclerosis Society. The new…
May 26, 2014 by Patricia Silva, PhD Multiple Sclerosis Drug Nerventra® (Laquinimod) Disapproved in EU; Drug Developers Will Continue Research Two pharmaceutical companies, Teva Pharmaceutical Industries Ltd. (TEVA) and Active Biotech, have just confirmed reports that the Committee for Medicinal Products for Human Use (CHMP) is not recommending NERVENTRA (laquinimod) for use in treating relapsing-remitting multiple sclerosis (RRMS) within the European Union (EU), according to a recent press release. Despite CHMP’s disapproval of TEVA…
May 26, 2014 by Patricia Silva, PhD Newly Acquired Patents For Multiple Sclerosis, Alzheimer’s DNA Therapies Spurs New Clinical Trials At Inovio Inovio Pharmaceuticals, a drug development company working on treatments that modulate therapeutically important immune responses with the help of T-cells, recently acquired the worldwide rights (apart from China), to conduct pre-clinical studies to produce products for possible therapies to treat and manage Alzheimer’s Disease (AD) and Multiple Sclerosis (MS).
May 20, 2014 by Patricia Silva, PhD Combination Therapy For Multiple Sclerosis Offers Promising Results In Recent Study Positive study results from a preliminary phase II clinical trial for a new potential therapeutic intervention for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) were recently released at the American Academy of Neurology’s Annual Meeting in Philadelphia by Dr. Rhonda Voskuhl, M.D., from the University of California, Los Angeles.
May 20, 2014 by Patricia Silva, PhD Researchers Explore Role of NAD In Cognitive Decline of Multiple Sclerosis Patients A group of researchers led by Shin-ichiro Imai, MD, PhD, and Liana Roberts Stein, PhD, from Washington University School of Medicine in St. Louis have been working on pathways to trace cognitive decline in patients with multiple sclerosis (MS). It has been noted in previous research that brain cells derive energy for maintaining…
May 19, 2014 by Patricia Silva, PhD Clinical Professor Holds Lecture On Using Paleo Diet To Control MS According to a recent article by Beth Roessner at the Desert Sun, some Multiple Sclerosis patients are beginning to utilize healthier diets and eating habits to complement conventional treatments for their disease — an approach that even some researchers are beginning to study. Erin Davis, a 40 year-old woman,…
May 16, 2014 by Patricia Silva, PhD New Secondary Progressive MS Drug Trial Completes Enrollment Opexa Therapeutics, Inc., a drug delivery company based in The Woodlands, Texas, has been making significant progress in researching and developing Tcelna®, a breakthrough T-cell immunotherapy for multiple sclerosis (MS). The company recently announced they have reached their enrollment mark for conducting a Phase IIb clinical trial to test Tcelna as a viable…
May 14, 2014 by Patricia Silva, PhD Risk of Neurodegenerative Diseases Such As Multiple Sclerosis Affected By Gene Expression, Immune System Response The diagnosis of a disease normally depends on the risk factors one is exposed to during his or her lifetime, and subsequently therapeutic measures are taken in order to treat the same with hopes of a better prognosis and a healthy lifestyle. However, scientists at the Brigham and Women’s Hospital…
May 11, 2014 by Patricia Silva, PhD Low Fat Diets Benefit Multiple Sclerosis Patients, According To New Study A small scale study undertaken by researchers at the Department of Neurology, Oregon Health & Science University (OSHU) showed the benefits of maintaining a low-fat diet in improving fatigue related to multiple sclerosis (MS). The study was led by Dr. Vijayshree Yadav, M.D., an associate professor of neurology in…